Viridian Therapeutics Inc (NASDAQ:VRDN)

22.60
Delayed Data
As of 3:59pm ET
 -0.21 / -0.92%
Today’s Change
9.47
Today|||52-Week Range
26.22
+14.31%
Year-to-Date

Today’s Trading

Previous close22.81
Today’s open23.13
Day’s range22.32 - 23.25
Volume9,807
Average volume (3 months)680,606
Market cap$923.3M
Data as of 3:59pm ET, 11/28/2022

Growth & Valuation

Earnings growth (last year)+78.59%
Earnings growth (this year)+46.29%
Earnings growth (next 5 years)+7.59%
Revenue growth (last year)+182.19%
P/E ratioNM
Price/Sales79.53
Price/Book10.19

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc-0.13-0.96%
----
----
VRNAVerona Pharma PLC-0.20-1.59%
Data as of 4:00pm ET, 11/28/2022

Financials

Next reporting dateMarch 15, 2023
EPS forecast (this quarter)-$0.75
Annual revenue (last year)$3.0M
Annual profit (last year)-$79.4M
Net profit margin-2,680.16%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Waltham, Massachusetts

Forecasts